Skip to main content
Acta Crystallographica Section E: Crystallographic Communications logoLink to Acta Crystallographica Section E: Crystallographic Communications
. 2017 Jun 7;73(Pt 7):967–970. doi: 10.1107/S2056989017008155

Crystal structure of 4-benzyl­carbamoyl-1-methyl­pyridin-1-ium iodide: an efficient multimodal anti­viral drug

T N Drebushchak a,b,*, YuA Kryukov c, A I Rogova c, E V Boldyreva a,b
PMCID: PMC5499270  PMID: 28775862

Polymorph screening of the title compound, an efficient multimodal anti­viral drug, revealed only a single polymorph, for which the crystal structure is determined in this work.

Keywords: crystal structure, drug, polymorphism

Abstract

In the title compound, [MeC5H4NCONHCH2C6H5]I or C14H15N2O+·I, a cation and an anion form an ionic pair linked by a strong N—H⋯I hydrogen bond. In the crystal, ionic pairs linked by weak C—H⋯I hydrogen bonds form infinite ribbons along the crystallographic a axis. Polymorphism screening varying crystallization solvents (water, acetone 90%–water, ethanol 90%–water, 2-propanol 90%–water, DMF, DMSO, methanol, aceto­nitrile) and conditions (solution temperature, heating and cooling protocols) did not reveal any other polymorphs than the one reported in this work.

Chemical context  

4-Benzyl­carbamoyl-1-methyl­pyridin-1-ium iodide, [MeC5H4NCONHCH2C6H5]I, is a multimodal anti­viral drug (Buhtiarova et al., 2003; Frolov et al., 2004). For pharmaceutical applications, it is of utmost importance to identify possible polymorphs (Bernstein, 2002; Brittain, 1999; Hilfiker, 2006), see also https://www.fda.gov/downloads/Drugs/Guidances/UCM072866.pdf; https://newdrugapprovals.org/2014/02/12/fda-guidance-on-polymorphic-compounds-in-generic-drugs/. Polymorphism screening varying crystallization solvents (water, acetone 90%–water, ethanol 90%–water, iso­propanol 90%–water, DMF, DMSO, MeOH, CH3CN) and conditions (solution temperature, heating and cooling protocols) did not reveal any other polymorphs than the one reported in this work as has been confirmed by DSC (METTLER TOLEDO DSC 822e, 5° min−1 in N2, samples 1/6–3/5 mg), IR spectroscopy (IR–FT spectrometer FT–801, spectroscopic resolution 0.5 cm−1 and systematic error ±0,05 cm−1; samples studied in KBr discs, 1.0 mg of substance in 200 mg of KBr; 4000–600 cm−1, and FTIR ATR spectrometer DigiLab Excalibur 3100, Varian spectrometer equipped with a MIRacle ATR accessory in the range 4000–600 cm−1 with resolution of 2 cm−1 without addition of KBr) and X-ray powder diffraction (STOE STADI MP diffractometer, CuKα1 radiation, curved Ge monochromator, transmission mode). The same thermal effect at the DSC curves related to sample melting at 464 K has been observed for all the samples. The position and relative intensities of the bands in the IR spectra were also the same (see section 5, Fig. 1). There were no differences between the IR spectra recorded with and without addition of KBr. The X-ray diffraction patterns were also the same for all the samples (Fig. 2) and matched the pattern calculated for the structural model based on single-crystal diffraction data (see next sections). WinXPOW (Stoe & Cie, 2011) was used to analyze the diffraction patterns.graphic file with name e-73-00967-scheme1.jpg

Figure 1.

Figure 1

IR spectra of the title compound.

Figure 2.

Figure 2

Powder diffraction patterns of the samples recrystallized from different solvents (an overlay) (a) and the diffraction pattern calculated for the structural model obtained based on single-crystal X-ray diffraction data in this work (b).

Structural commentary  

The asymmetric unit of the title compound contains a [MeC5H4NCONHCH2C6H5]+ cation and an I anion (Fig. 3). All the bond lengths and angles are within normal ranges. A cation and an anion form an ionic pair linked by a strong N2—H2⋯I1 hydrogen bond (Table 1). The central part of the mol­ecule (N2/C8/O1) and the pyridyl ring are located practically in the same plane [the average deviation of the atoms from the N1/N2/O1/C8–C13 plane is 0.015 (3) Å and the maximum deviation is 0.025 (3) Å]. The I anion is also close to this plane [at a distance of 0.504 (3) Å]. The dihedral angle between the pyridyl and benzene rings is 62.8 (1)°.

Figure 3.

Figure 3

The mol­ecular structure of the title compound, showing the atom-labelling scheme. Displacement ellipsoids are drawn at the 50% probability level. H atoms are shown as spheres of arbitrary radius. The dotted line indicates the N—H⋯I hydrogen bond.

Table 1. Hydrogen-bond geometry (Å, °).

D—H⋯A D—H H⋯A DA D—H⋯A
N2—H2⋯I1 0.98 (6) 2.68 (6) 3.563 (3) 150 (5)
C14—H14A⋯I1i 0.96 3.08 4.018 (5) 168
C14—H14C⋯I1ii 0.96 3.06 3.919 (5) 150

Symmetry codes: (i) Inline graphic; (ii) Inline graphic.

Supra­molecular features  

In addition to the strong NH⋯I hydrogen bond, two weak C—H⋯I hydrogen bonds are present in the crystal structure (Table 1, Fig. 4). Ionic pairs linked by these hydrogen bonds form infinite ribbons along the crystallographic a axis (Fig. 4). No hydrogen bonds link the ribbons with each other.

Figure 4.

Figure 4

Crystal packing of the title compound, viewed (a) along the b axis and (b) along the a axis. The dotted lines indicate the hydrogen bonds, N—H⋯I (blue) and C—H⋯I (olive).

Database survey  

No crystal structures containing the [MeC5H4NCONHCH2C6H5]+ cation could be found in the Cambridge Structural Database (CSD, Version 5.38, update November 2016; Groom et al., 2016). A crystal structure of 4-benzoyl­amino-1-methyl­pyridinium iodide (CSD refcode ESESUS; Navarro et al., 2016) is also formed by ionic pairs linked by a strong N—H⋯I hydrogen bond [the donor–acceptor distance is 3.675 (1) Å]. Similarly to the compound studied in this work, the organic cation of ESESUS also contains a benzene and an N-methyl­pyridine ring, with the N atom forming an N—H⋯I hydrogen bond in the centre of the cation (Fig. 5). Since the central part of the cation in the case of ESESUS is shorter than that of the title compound, the mol­ecular conformation is very different, as is the mol­ecular packing (Fig. 5).

Figure 5.

Figure 5

The mol­ecular structure and crystal packing of 4-benzoyl­amino-1-methyl­pyridinium iodide (a) and of the title compound (b).

Synthesis and crystallization  

The title compound can be synthesized from N-benzyl­amide 4-pyridine­carb­oxy­lic acid C5H4NCONHCH2C6H5 and methyl iodide MeI in a 1:2 (Trinus et al., 1994) or 1:1.2 (Buhtiarova et al., 1997) molar ratio. N-Benzyl­amide 4-pyridine­carb­oxy­lic acid, in turn, was synthesized by the condensation of iso­nico­tinic acid C5H4NCOOH with benzyl­amine C6H5CH2NH2 taken in a 1:2 molar ratio (Trinus et al., 1994).

12.31 g (0.1 mol) of isonicotinic acid were added with constant stirring over a period of one hour to 12.86 g (0.12 mol) of benzyl­amine heated to 413 K. After all of the isonicotinic acid had been added, the mixture was heated steadily to 493–503 K. After water and the excess of benzamine had been distilled, the residue was cooled to 373–383 K and added on stirring to 100 ml of toluene. The hot solution was filtered and cooled to 288 K. After cooling, the precipitate was filtered, washed on the filter with 20 ml of toluene and dried in the air at ambient temperature. The yield was 18.57 g (0.0875 mol; 87.5%) (Sysoljatin et al., 2011).

18.57 g (0.0875 mol) of N-benzyl­amide 4-pyridine­carb­oxy­lic acid were added to 110 ml of acetone with stirring. After the dissolution was complete, 14.9 g (0.105 mol) of methyl iodide MeI were added and the reaction mixture kept at 323 K for five h after which it was cooled to 283–288 K and filtered. The precipitate was washed on the filter with 50 ml of acetone and dried in the air. The yield was 24.65 g (0.0696 mol; 79.5%) (Sysoljatin et al., 2011).

Calculated for C14H15N2OI: C, 47.46; H, 4.21: N, 7.91; O, 4.52. Found: C, 47.31; H, 4.13: N, 7.62; O, 4.35. Tmelt. 464 K. IR spectrum (cm−1): 611.27, 631.44, 703.72, 777.41, 759.32, 860.4, 920.77, 960.85, 1020.8, 1078.2, 1147.6, 1187.8, 1218.8, 1285.4, 1329.8, 1416.4, 1452.5, 1505.1, 1541.1, 1571.6, 1663.7, 1641.4, 1828.1, 1950.9, 2828.6, 2936.6, 3040.4, 3237.6. 1H NMR (400 MHz, DMSO-d 6, p.p.m.): δ = 4.40 (s, 3H, CH3), 4.55 (d, 2H, CH2), 7.22–7.45 (m, 5H, Ar), 8.44 (d, 2H, Py), 9.19 (d, 2H, Py), 9.78 (s, H, NH). 13C–1H NMR (100 MHz, DMSO-d 6, p.p.m.): δ = 43.89 (CH2), 49.00 (CH3), 125.95, 147.06, 148.20 (Py), 127.65, 128.01, 128.92, 139.18 (Ar), 162.63 (C=O).

The pharmaceutical substance was obtained by recrystal­lization from an aqueous solution with activated carbon (Sysoljatin et al., 2011). 5.0 g (0.014 mol) of N-methyl-4-benzyl­carbamido­pyridinium iodide were dissolved in 6 ml of water at 363 K and 0.15 g (3.0%) of activated carbon added. After the complete dissolution of the compound, the activated carbon was removed by filtering, and the solution was cooled to 283 K. After stirring for one hour, the precipitate formed was filtered through a paper filter (white band), washed with 10 ml of acetone and dried at 373 K. Yield 4.71 g (0.0133 mol; 94.3%).

Refinement  

Crystal data, data collection and structure refinement details are summarized in Table 2. The amine hydrogen atom bound to N2 was located in the difference maps and refined isotropically. All other hydrogen atoms were positioned geom­etrically and refined with a riding model [C—H = 0.93–0.97 Å; U iso(H) = 1.2–1.5U eq(C)].

Table 2. Experimental details.

Crystal data
Chemical formula C14H15N2O+·I
M r 354.18
Crystal system, space group Orthorhombic, P212121
Temperature (K) 295
a, b, c (Å) 9.2867 (2), 10.8741 (2), 14.3038 (3)
V3) 1444.46 (5)
Z 4
Radiation type Mo Kα
μ (mm−1) 2.21
Crystal size (mm) 0.25 × 0.17 × 0.07
 
Data collection
Diffractometer Rigaku OD Xcalibur, Ruby, Gemini ultra
Absorption correction Multi-scan (CrysAlis PRO; Rigaku OD, 2015)
T min, T max 0.910, 1.000
No. of measured, independent and observed [I > 2σ(I)] reflections 18978, 3388, 3115
R int 0.033
(sin θ/λ)max−1) 0.666
 
Refinement
R[F 2 > 2σ(F 2)], wR(F 2), S 0.024, 0.053, 1.08
No. of reflections 3388
No. of parameters 168
H-atom treatment H atoms treated by a mixture of independent and constrained refinement
Δρmax, Δρmin (e Å−3) 0.53, −0.35
Absolute structure Flack x determined using 1207 quotients [(I +)−(I )]/[(I +)+(I )] (Parsons et al., 2013)
Absolute structure parameter −0.033 (11)

Computer programs: CrysAlis PRO (Rigaku OD, 2015), SHELXS97 (Sheldrick, 2008), SHELXL2014 (Sheldrick, 2015), Mercury (Macrae et al., 2006), WinGX (Farrugia, 2012) and publCIF (Westrip, 2010).

Supplementary Material

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989017008155/rk2435sup1.cif

e-73-00967-sup1.cif (636.7KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989017008155/rk2435Isup2.hkl

e-73-00967-Isup2.hkl (270.5KB, hkl)

Supporting information file. DOI: 10.1107/S2056989017008155/rk2435Isup3.cml

CCDC reference: 1553547

Additional supporting information: crystallographic information; 3D view; checkCIF report

Acknowledgments

We thank Dr E. A. Losev for recording the FT–IR ATR spectra.

supplementary crystallographic information

Crystal data

C14H15N2O+·I Dx = 1.629 Mg m3
Mr = 354.18 Melting point: 464(2) K
Orthorhombic, P212121 Mo Kα radiation, λ = 0.71073 Å
a = 9.2867 (2) Å Cell parameters from 9574 reflections
b = 10.8741 (2) Å θ = 2.4–26.3°
c = 14.3038 (3) Å µ = 2.21 mm1
V = 1444.46 (5) Å3 T = 295 K
Z = 4 Block, yellow
F(000) = 696 0.25 × 0.17 × 0.07 mm

Data collection

Rigaku OD Xcalibur, Ruby, Gemini ultra diffractometer 3388 independent reflections
Radiation source: fine-focus sealed X-ray tube, Enhance (Mo) X-ray Source 3115 reflections with I > 2σ(I)
Graphite monochromator Rint = 0.033
Detector resolution: 10.3457 pixels mm-1 θmax = 28.3°, θmin = 2.4°
ω scans h = −12→12
Absorption correction: multi-scan (CrysAlis PRO; Rigaku OD, 2015) k = −14→13
Tmin = 0.910, Tmax = 1.000 l = −18→18
18978 measured reflections

Refinement

Refinement on F2 Secondary atom site location: difference Fourier map
Least-squares matrix: full Hydrogen site location: mixed
R[F2 > 2σ(F2)] = 0.024 H atoms treated by a mixture of independent and constrained refinement
wR(F2) = 0.053 w = 1/[σ2(Fo2) + (0.0267P)2 + 0.0479P] where P = (Fo2 + 2Fc2)/3
S = 1.08 (Δ/σ)max < 0.001
3388 reflections Δρmax = 0.53 e Å3
168 parameters Δρmin = −0.35 e Å3
0 restraints Absolute structure: Flack x determined using 1207 quotients [(I+)-(I-)]/[(I+)+(I-)] (Parsons et al., 2013)
Primary atom site location: structure-invariant direct methods Absolute structure parameter: −0.033 (11)

Special details

Geometry. All s.u.'s (except the s.u. in the dihedral angle between two l.s. planes) are estimated using the full covariance matrix. The cell s.u.'s are taken into account individually in the estimation of s.u.'s in distances, angles and torsion angles; correlations between s.u.'s in cell parameters are only used when they are defined by crystal symmetry. An approximate (isotropic) treatment of cell s.u.'s is used for estimating s.u.'s involving l.s. planes.

Fractional atomic coordinates and isotropic or equivalent isotropic displacement parameters (Å2)

x y z Uiso*/Ueq
C1 0.1886 (4) 0.0803 (3) 0.9728 (2) 0.0423 (8)
C2 0.2939 (4) 0.0665 (4) 1.0407 (3) 0.0475 (9)
H1 0.3631 0.0054 1.0338 0.057*
C3 0.2982 (5) 0.1404 (4) 1.1172 (3) 0.0583 (11)
H3 0.3702 0.1296 1.1617 0.070*
C4 0.1975 (6) 0.2307 (5) 1.1293 (3) 0.0739 (13)
H4 0.2012 0.2817 1.1814 0.089*
C5 0.0909 (6) 0.2452 (5) 1.0639 (4) 0.0805 (16)
H5 0.0210 0.3054 1.0723 0.097*
C6 0.0869 (5) 0.1713 (4) 0.9858 (3) 0.0654 (12)
H6 0.0149 0.1827 0.9414 0.078*
C7 0.1838 (5) −0.0028 (4) 0.8892 (3) 0.0555 (10)
H7A 0.2008 −0.0868 0.9093 0.067*
H7B 0.0882 0.0006 0.8619 0.067*
C8 0.4168 (4) −0.0275 (3) 0.8098 (3) 0.0456 (8)
C9 0.5104 (4) 0.0078 (3) 0.7283 (3) 0.0407 (8)
C10 0.4765 (4) 0.0948 (4) 0.6614 (3) 0.0477 (9)
H10 0.3906 0.1385 0.6656 0.057*
C11 0.5694 (5) 0.1168 (4) 0.5888 (3) 0.0504 (9)
H11 0.5455 0.1751 0.5439 0.060*
C12 0.7303 (5) −0.0274 (5) 0.6477 (3) 0.0677 (13)
H12 0.8177 −0.0686 0.6432 0.081*
C13 0.6423 (5) −0.0514 (5) 0.7198 (3) 0.0627 (12)
H13 0.6700 −0.1084 0.7648 0.075*
C14 0.7913 (5) 0.0782 (5) 0.5020 (3) 0.0705 (13)
H14A 0.7477 0.1364 0.4602 0.106*
H14B 0.8087 0.0025 0.4694 0.106*
H14C 0.8810 0.1107 0.5246 0.106*
N1 0.6942 (4) 0.0555 (3) 0.5815 (2) 0.0494 (8)
N2 0.2902 (3) 0.0295 (3) 0.8172 (2) 0.0475 (7)
H2 0.262 (7) 0.085 (6) 0.766 (4) 0.12 (2)*
O1 0.4598 (4) −0.1053 (3) 0.86557 (19) 0.0634 (8)
I1 0.06127 (3) 0.22276 (3) 0.68164 (2) 0.05375 (9)

Atomic displacement parameters (Å2)

U11 U22 U33 U12 U13 U23
C1 0.0396 (19) 0.0438 (18) 0.0435 (18) −0.0051 (15) 0.0082 (17) 0.0088 (16)
C2 0.0350 (19) 0.057 (2) 0.050 (2) 0.0010 (16) 0.0021 (18) 0.0085 (19)
C3 0.055 (3) 0.075 (3) 0.044 (2) −0.014 (2) 0.002 (2) 0.003 (2)
C4 0.103 (4) 0.069 (3) 0.050 (2) −0.011 (3) 0.018 (3) −0.011 (2)
C5 0.096 (4) 0.069 (3) 0.076 (3) 0.033 (3) 0.016 (3) 0.000 (2)
C6 0.059 (3) 0.078 (3) 0.059 (3) 0.023 (2) −0.002 (2) 0.015 (2)
C7 0.052 (2) 0.063 (3) 0.051 (2) −0.015 (2) 0.002 (2) −0.0028 (19)
C8 0.051 (2) 0.0456 (19) 0.0401 (18) −0.0024 (16) −0.011 (2) −0.0033 (16)
C9 0.0420 (19) 0.042 (2) 0.0382 (19) −0.0002 (15) −0.0065 (16) −0.0043 (15)
C10 0.048 (2) 0.047 (2) 0.048 (2) 0.0084 (16) −0.0015 (17) −0.0013 (16)
C11 0.054 (2) 0.048 (2) 0.049 (2) 0.002 (2) −0.004 (2) 0.0057 (16)
C12 0.046 (3) 0.087 (4) 0.070 (3) 0.020 (2) 0.002 (2) 0.012 (3)
C13 0.056 (3) 0.076 (3) 0.055 (2) 0.021 (2) −0.002 (2) 0.018 (2)
C14 0.058 (3) 0.097 (4) 0.057 (3) −0.001 (3) 0.010 (2) 0.004 (3)
N1 0.0408 (17) 0.061 (2) 0.0463 (17) −0.0012 (15) −0.0045 (15) −0.0002 (15)
N2 0.0472 (18) 0.0553 (19) 0.0400 (16) 0.0010 (14) 0.0006 (18) −0.0012 (17)
O1 0.068 (2) 0.0664 (18) 0.0562 (15) 0.0077 (17) −0.0044 (16) 0.0181 (15)
I1 0.05146 (14) 0.05593 (15) 0.05386 (14) 0.01142 (12) −0.00363 (13) −0.00252 (12)

Geometric parameters (Å, º)

C1—C6 1.381 (6) C8—C9 1.504 (5)
C1—C2 1.387 (5) C9—C10 1.383 (5)
C1—C7 1.500 (5) C9—C13 1.389 (6)
C2—C3 1.358 (6) C10—C11 1.371 (5)
C2—H1 0.9300 C10—H10 0.9300
C3—C4 1.367 (7) C11—N1 1.341 (5)
C3—H3 0.9300 C11—H11 0.9300
C4—C5 1.371 (7) C12—C13 1.342 (6)
C4—H4 0.9300 C12—N1 1.349 (5)
C5—C6 1.376 (7) C12—H12 0.9300
C5—H5 0.9300 C13—H13 0.9300
C6—H6 0.9300 C14—N1 1.472 (5)
C7—N2 1.469 (5) C14—H14A 0.9600
C7—H7A 0.9700 C14—H14B 0.9600
C7—H7B 0.9700 C14—H14C 0.9600
C8—O1 1.229 (4) N2—H2 0.98 (6)
C8—N2 1.334 (5)
C6—C1—C2 117.7 (4) C10—C9—C13 117.2 (4)
C6—C1—C7 121.3 (4) C10—C9—C8 125.5 (3)
C2—C1—C7 121.0 (4) C13—C9—C8 117.3 (4)
C3—C2—C1 121.4 (4) C11—C10—C9 120.0 (4)
C3—C2—H1 119.3 C11—C10—H10 120.0
C1—C2—H1 119.3 C9—C10—H10 120.0
C2—C3—C4 120.4 (4) N1—C11—C10 121.1 (4)
C2—C3—H3 119.8 N1—C11—H11 119.4
C4—C3—H3 119.8 C10—C11—H11 119.4
C3—C4—C5 119.4 (4) C13—C12—N1 121.2 (4)
C3—C4—H4 120.3 C13—C12—H12 119.4
C5—C4—H4 120.3 N1—C12—H12 119.4
C4—C5—C6 120.4 (4) C12—C13—C9 120.9 (4)
C4—C5—H5 119.8 C12—C13—H13 119.5
C6—C5—H5 119.8 C9—C13—H13 119.5
C5—C6—C1 120.6 (4) N1—C14—H14A 109.5
C5—C6—H6 119.7 N1—C14—H14B 109.5
C1—C6—H6 119.7 H14A—C14—H14B 109.5
N2—C7—C1 113.2 (3) N1—C14—H14C 109.5
N2—C7—H7A 108.9 H14A—C14—H14C 109.5
C1—C7—H7A 108.9 H14B—C14—H14C 109.5
N2—C7—H7B 108.9 C11—N1—C12 119.4 (4)
C1—C7—H7B 108.9 C11—N1—C14 120.4 (3)
H7A—C7—H7B 107.8 C12—N1—C14 120.2 (4)
O1—C8—N2 123.7 (4) C8—N2—C7 122.5 (4)
O1—C8—C9 119.4 (4) C8—N2—H2 118 (4)
N2—C8—C9 116.9 (3) C7—N2—H2 119 (4)
C6—C1—C2—C3 −0.6 (6) C13—C9—C10—C11 2.1 (6)
C7—C1—C2—C3 −179.3 (4) C8—C9—C10—C11 −178.4 (3)
C1—C2—C3—C4 0.3 (6) C9—C10—C11—N1 −0.4 (6)
C2—C3—C4—C5 0.6 (7) N1—C12—C13—C9 0.5 (8)
C3—C4—C5—C6 −1.2 (8) C10—C9—C13—C12 −2.2 (7)
C4—C5—C6—C1 0.9 (8) C8—C9—C13—C12 178.2 (4)
C2—C1—C6—C5 0.0 (6) C10—C11—N1—C12 −1.4 (6)
C7—C1—C6—C5 178.7 (4) C10—C11—N1—C14 178.7 (4)
C6—C1—C7—N2 103.1 (4) C13—C12—N1—C11 1.3 (7)
C2—C1—C7—N2 −78.2 (5) C13—C12—N1—C14 −178.7 (5)
O1—C8—C9—C10 −179.0 (4) O1—C8—N2—C7 −5.2 (6)
N2—C8—C9—C10 0.6 (5) C9—C8—N2—C7 175.1 (3)
O1—C8—C9—C13 0.5 (5) C1—C7—N2—C8 97.8 (4)
N2—C8—C9—C13 −179.8 (4)

Hydrogen-bond geometry (Å, º)

D—H···A D—H H···A D···A D—H···A
N2—H2···I1 0.98 (6) 2.68 (6) 3.563 (3) 150 (5)
C14—H14A···I1i 0.96 3.08 4.018 (5) 168
C14—H14C···I1ii 0.96 3.06 3.919 (5) 150

Symmetry codes: (i) x+1/2, −y+1/2, −z+1; (ii) x+1, y, z.

References

  1. Bernstein, J. (2002). In Polymorphism in Molecular Crystals. New York: Oxford University Press Inc.
  2. Brittain, H. G. (1999). In Polymorphism in Pharmaceutical Solids: London: Taylor & Francis.
  3. Buhtiarova, T. A., Danilenko, V. P., Homenko, V. S., Shatyrkina, T. V. & Yadlovsky, O. E. (2003). Ukrainian Med. J. 33, 72–74.
  4. Buhtiarova, T. A., Trinus, F. P., Danilenko, V. F., Danilenko, G. I., Ovrutskiy, V. M. & Sharykina, N. I. (1997). Khim. Farm. Zh. 31, 30–32.
  5. Farrugia, L. J. (2012). J. Appl. Cryst. 45, 849–854.
  6. Frolov, A. F., Frolov, V. M., Buhtiarova, T. A. & Danilenko, V. P. (2004). Ukrainian Med. J. 39, 69–74.
  7. Groom, C. R., Bruno, I. J., Lightfoot, M. P. & Ward, S. C. (2016). Acta Cryst. B72, 171–179. [DOI] [PMC free article] [PubMed]
  8. Hilfiker, R. (2006). Pharm. Ind. 1st ed. London: Wiley–VCH.
  9. Macrae, C. F., Edgington, P. R., McCabe, P., Pidcock, E., Shields, G. P., Taylor, R., Towler, M. & van de Streek, J. (2006). J. Appl. Cryst. 39, 453–457.
  10. Navarro, M., Li, M., Müller-Bunz, H., Bernhard, S. & Albrecht, M. (2016). Chem. Eur. J. 22, 6740–6745. [DOI] [PubMed]
  11. Parsons, S., Flack, H. D. & Wagner, T. (2013). Acta Cryst. B69, 249–259. [DOI] [PMC free article] [PubMed]
  12. Rigaku OD (2015). CrysAlis PRO. Rigaku Oxford Diffraction, Yarnton, Oxfordshire, England.
  13. Sheldrick, G. M. (2008). Acta Cryst. A64, 112–122. [DOI] [PubMed]
  14. Sheldrick, G. M. (2015). Acta Cryst. C71, 3–8.
  15. Stoe & Cie (2011). WinXPOW. Stoe & Cie GmbH, Darmstadt, Germany.
  16. Sysoljatin, S. V., Sakovich, G. V., Kryukov, Yu. A., Rogov, A. I., Bubelo, V. D. & Chernov, A. I. (2011). Patent 2429230, RF, 20.09.2011, Bull. 26.
  17. Trinus, F. P., Danilenko, V. F., Buhtiarova, T. A., Rybalko, S. L., Arkad’ev, V. G., Klebanov, B. M. & Maksimov, Yu. N. (1994). Patent 6752, Ukraine, 29.08.1994, Bull. ‘Promyslova vlasnist’ 8–1.
  18. Westrip, S. P. (2010). J. Appl. Cryst. 43, 920–925.

Associated Data

This section collects any data citations, data availability statements, or supplementary materials included in this article.

Supplementary Materials

Crystal structure: contains datablock(s) I. DOI: 10.1107/S2056989017008155/rk2435sup1.cif

e-73-00967-sup1.cif (636.7KB, cif)

Structure factors: contains datablock(s) I. DOI: 10.1107/S2056989017008155/rk2435Isup2.hkl

e-73-00967-Isup2.hkl (270.5KB, hkl)

Supporting information file. DOI: 10.1107/S2056989017008155/rk2435Isup3.cml

CCDC reference: 1553547

Additional supporting information: crystallographic information; 3D view; checkCIF report


Articles from Acta Crystallographica Section E: Crystallographic Communications are provided here courtesy of International Union of Crystallography

RESOURCES